Skip to main content

Table 7 Studies discussing Wilms’ tumor survival in different centers in Egypt

From: Localized Wilms’ tumor in low-middle-income countries (LMIC): how can we get better?

Study

Results

(Zaghloul, Hussein, & El Koutbey, 1994) [16]

112 cases have been treated at NCI during the period 1979–1989

10-year OS of stage I, II, and III patients with favorable histology was 94 ± 6%, 86 ± 8%, and 71 ± 8%, respectively.

(Abd El-Aal, Habib, & Mishrif, 2005) [17]

62 cases have been treated at the pediatric unit of Kasr El-Aini center of radiation oncology and nuclear Medicine (NEMROCK) from January 1994 to January 2001.

Stages I, II, and III + IV + V with favorable histology had a 4-year overall survival of 82.3, 56, and 41%, respectively.

(Naguib et al., 2008) [18]

53 cases have been treated at NCI between 2002 and 2004.

2-year OS of stages I, II, and III was 100, 100, and 61.2%, respectively.

(Salama & Kamel, 2011) [9]

65 cases have been treated at NCI between 2001 and 2008.

3-year RFS and OS for stage I, II and III were 75.4 and 77.8%, respectively.

(Elmagd Salem, Kinoshita, Abdelkhader, Hamza, & Ali, 2013) [19]

79 patients treated at the South Egypt Cancer Institute from 2002 to 2009 according to the SIOP protocol. The overall 5-year survival rate of 84% with a 5-year stage-related survival was as follows: I = 92%, II = 80%, III = 50%

33 patients treated at the Pediatric Surgery Department of Assiut University Hospital from 2000 to 2009 according to the NWTS protocol. The overall 5-year survival rate was 77% and the 5-year stage-related survival was as follows: I = 85%, II = 75%, III = 52%.

(El-­-ayadi et al., 2014) [15]

98 cases have been treated at NCI and CCHE from 2010 to 2011

3-year OS for stage I/II and stage III was 95.7% and 94.7% respectively.